CAMLG antibody
Quick Overview for CAMLG antibody (ABIN2717006)
Target
See all CAMLG AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Characteristics
- Homo sapiens calcium modulating ligand (CAMLG)
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human CAMLG(NP_001736) produced in HEK293T cell.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB 1:2000, IHC 1:150, IF 1:100, FLOW 1:100,
-
Comment
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- CAMLG (Calcium Modulating Ligand (CAMLG))
-
Alternative Name
- CAMLG
-
Background
- The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. The protein encoded by this gene functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin.
-
Molecular Weight
- 32.8 kDa
-
Gene ID
- 819
-
NCBI Accession
- NM_001745
-
HGNC
- 819
-
Pathways
- EGFR Signaling Pathway
Target
-